| Overview |
| bs-9182R-Cy3 |
| VGLL1 Polyclonal Antibody, Cy3 Conjugated |
| WB, IF |
| Human |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human VGLL1 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 51442 |
| TDU; VGL1; VGL 1; VGL-1; TONDU; Transcription cofactor vestigial like protein 1; Vestigial like 1; VGLL1_HUMAN. |
| VGLL1 is a specific coactivator for the mammalian TEFs. The mammalian TEF and the Drosophila scalloped genes belong to a conserved family of transcriptional factors that possesses a TEA/ATTS DNA binding domain. |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
IHC-P1:50-200 |
Powered by Bioz